```

[Federal Register Volume 89, Number 224 (Wednesday, November 20, 2024)]
[Notices]
[Page 91786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26998]

-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 701-TA-737-738 and 731-TA-1712-1715 (Preliminary)]

Hexamine (Hexamethylenetetramine) From China, Germany, India, and 
Saudi Arabia

Determinations

    On the basis of the record \1\ developed in the subject 
investigations, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that there is a reasonable indication that an industry in the 
United States is materially injured by reason of imports of hexamine 
(hexamethylenetetramine) from China, Germany, India, and Saudi Arabia, 
provided for in subheading 2933.69.50 of the Harmonized Tariff Schedule 
of the United States, that are alleged to be sold in the United States 
at less than fair value (``LTFV'') and imports of the subject 
merchandise from China and India that are alleged to be subsidized by 
the governments of China and India.2 3
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
    \2\ 89 FR 87545 and 87560 (November 4, 2024).
    \3\ Chair Karpel determines that there is a reasonable 
indication that an industry in the United States is threatened with 
material injury by reason of imports of hexamine from China, 
Germany, India, and Saudi Arabia that are alleged to be sold in the 
United States at LTFV and imports of the subject merchandise from 
China and India that are alleged to be subsidized by the governments 
of China and India.
---------------------------------------------------------------------------

Commencement of Final Phase Investigations

    Pursuant to section 207.18 of the Commission's rules, the 
Commission also gives notice of the commencement of the final phase of 
its investigations. The Commission will issue a final phase notice of 
scheduling, which will be published in the Federal Register as provided 
in Sec.  207.21 of the Commission's rules, upon notice from the U.S. 
Department of Commerce (``Commerce'') of affirmative preliminary 
determinations in the investigations under Sec. Sec.  703(b) or 733(b) 
of the Act, or, if the preliminary determinations are negative, upon 
notice of affirmative final determinations in those investigations 
under Sec. Sec.  705(a) or 735(a) of the Act. Parties that filed 
entries of appearance in the preliminary phase of the investigations 
need not enter a separate appearance for the final phase of the 
investigations. Any other party may file an entry of appearance for the 
final phase of the investigations after publication of the final phase 
notice of scheduling. Industrial users, and, if the merchandise under 
investigation is sold at the retail level, representative consumer 
organizations have the right to appear as parties in Commission 
antidumping and countervailing duty investigations. The Secretary will 
prepare a public service list containing the names and addresses of all 
persons, or their representatives, who are parties to the 
investigations. As provided in section 207.20 of the Commission's 
rules, the Director of the Office of Investigations will circulate 
draft questionnaires for the final phase of the investigations to 
parties to the investigations, placing copies on the Commission's 
Electronic Document Information System (EDIS, https://edis.usitc.gov), 
for comment.

Background

    On September 30, 2024, Bakelite Synthetics (Atlanta, Georgia) filed 
petitions with the Commission and Commerce, alleging that an industry 
in the United States is materially injured or threatened with material 
injury by reason of subsidized imports of hexamine from China and India 
and LTFV imports of hexamine from China, Germany, India, and Saudi 
Arabia. Accordingly, effective September 30, 2024, the Commission 
instituted countervailing duty investigation Nos. 701-TA-737-738 and 
antidumping duty investigation Nos. 731-TA-1712-1715 (Preliminary).
    Notice of the institution of the Commission's investigations and of 
a public conference to be held in connection therewith was given by 
posting copies of the notice in the Office of the Secretary, U.S. 
International Trade Commission, Washington, DC, and by publishing the 
notice in the Federal Register on October 4, 2024 (89 FR 80929). The 
Commission conducted its conference on October 21, 2024. All persons 
who requested the opportunity were permitted to participate.
    The Commission made these determinations pursuant to Sec. Sec.  
703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It 
completed and filed its determinations in these investigations on 
November 14, 2024. The views of the Commission are contained in USITC 
Publication 5563 (November 2024), entitled Hexamine 
(Hexamethylenetetramine) from China, Germany, India, and Saudi Arabia: 
Investigation Nos. 701-TA-737-738 and 731-TA-1712-1715 (Preliminary).

    By order of the Commission.

    Issued: November 14, 2024.
Sharon Bellamy,
Supervisory Hearings and Information Officer.
[FR Doc. 2024-26998 Filed 11-19-24; 8:45 am]
BILLING CODE 7020-02-P
```